Download a Corporate Presentation

Click here You can also access a copy here . Please email as@aipinvest.com for further information on how we might work together




Who we are

AIP-Lifesciences is an international service, advisory and investment firm focused on the global lifesciences sector. We provide a competitive range of flexible services that includes capital introduction, business development, principal investment, company incubation and acceleration, deal screening, research and business support, and accessing human capital.

Our entrepreneurial team serves a diverse range of industries and clients across investment and financial services, industry, and professional services. This includes corporates, investment banks, accountancy firms, management consultancies, and law firms amongst others. In addition, we serve a broad range of public and private market lifesciences-focused investors including institutions, private equity, family offices, hedge funds, sovereign wealth funds, endowments, foundations and many more…

  • AI/ML
  • Biotechnology
  • Digital Health
  • Healthcare
  • Medical Devices
  • Pharmacology
  • R&D

Some numbers

Within our team

THOUSAND+ STRONG LIFESCIENCES NETWORK

+ RESEARCH PROJECTS COMPLETED

THOUSAND+ LIFESCIENCES INVESTORS ACCESSIBLE

+ DEALS ORIGINATED

What we do

Our services

Principal Investment

Generating long-term capital growth by investing in the lifesciences sector both as principals and alongside a consortium of investment partners.

read more

INCUBATION & ACCELERATION

Establishing, structuring, staffing and raising capital for a broad range of customised lifesciences-focused businesses and investment platforms.

read more

CAPITAL INTRODUCTION

Providing capital introduction services to firms globally with extensive access to international investors across the private and public markets.

read more

SCREENING and ADVICE

Helping you to select and manage investments and personnel through carefully considered sector-focused due diligence and expert advice.

read more

BUSINESS DEVELOPMENT

Creating and augmenting your business development funnel through access to our international network of lifesciences-focused businesses and investors.

read more

Human Capital

Providing international junior through to executive level recruitment services on a permanent, consultancy and real-time basis.

read more

ORIGINATION

Sourcing new investment opportunities for our clients from both the public domain and AIP’s specialist opportunity origination network.

read more

RESEARCH

Providing on-call research services on virtually any topic ranging from micro tasks (hours) through to full project research (days/weeks) and everything in between.

read more

Business Support

A lifesciences concierge service. This has included Equity Research, Asset Modelling, Web Application Development, Video Production and IR assistance.

read more

MEET A FEW OF OUR TEAM

  • JAMES MCDOWELL

    RELEVANT EXPERIENCE:
    GFG, ICE, JP MORGAN
    EDUCATION:
    RHODES UNIVERSITY, IMPERIAL COLLEGE LONDON
  • PROFESSOR AIDAN O’SULLIVAN

    RELEVANT EXPERIENCE:
    ENRGEO, UCL, MIT, ALAN TURNING INSTITUTE, DUNNHUMBY
    EDUCATION:
    IMPERIAL COLLEGE LONDON, UNIVERSITY COLLEGE CORK (UCC)
  • JON HENDERSON

    RELEVANT EXPERIENCE:
    FOSTER FINDLAY ASSOCIATES, NHS
    EDUCATION:
    UNIVERSITY OF BIRMINGHAM, UNIVERSITY OF NOTTINGHAM
  • ANTONY SOMMERFELD

    RELEVANT EXPERIENCE:
    ENRGEO, AIP, ADAMANT VENTURES, DRS-COMMODITIES, BP, GOLDMAN SACHS, HSBC
    EDUCATION:
    IMPERIAL COLLEGE LONDON, UNIVERSITY COLLEGE LONDON (UCL)
  • DR. CHRISTIAN BUKOVICS – AIP ENERGY VENTURES

    RELEVANT EXPERIENCE:
    SHELL
    EDUCATION:
    UNIVERSITY OF VIENNA
  • ROBERT VAN DER ZALM – AIP ENERGY VENTURES

    RELEVANT EXPERIENCE:
    NOBLE GROUP, BHP BILLITON, SHELL, UNILVER
    EDUCATION:
    University of Oxford
  • JORGE BALDI

    RELEVANT EXPERIENCE:
    CYGNUS ENERGY. REPSOL. ENI REPSA
    EDUCATION:
    UNIVERSITY OF BUENOS AIRES (UBA)
  • COLIN HOWARD

    RELEVANT EXPERIENCE:
    CTH RESOURCE ECONOMICS, BG GROUP, SCHLUMBERGER
    EDUCATION:
    IMPERIAL COLLEGE LONDON
  • JOEL CORCORAN

    RELEVANT EXPERIENCE:
    ENRGEO, HANSA HYDROCARBONS, TULLOW OIL, PALLADIN RESOURCES
    EDUCATION:
    IMPERIAL COLLEGE LONDON, UNIVERSITY COLLEGE LONDON (UCL)
  • DR. SHAH ISLAM

    RELEVANT EXPERIENCE:
    IMPERIAL COLLEGE LONDON, NHS, HARDIAN HEALTH
    EDUCATION:
    IMPERIAL COLLEGE LONDON, BARTS AND THE LONDON SCHOOL OF MEDICINE AND DENTISTRY
  • LYNDA WILSON

    RELEVANT EXPERIENCE:
    EXXON MOBIL, SHELL

WHAT SETS US APART

Our DIFFERENTIATORS

Our Team

Partner with a team of best in class industry, banking and finance and professional services experts.

Our Access

Benefit from our market relationships and access to over 50,000 lifesciences professionals.

Our Track Record

Leverage our exceptional track record of delivery across a range of industries, transactions and service offerings.

A few examples of current work

AIP has an exceptional track record of delivery across the lifesciences sector.

Our team is regularly engaged to deliver value to clients across a diverse range of markets and geographies. This includes opportunities to raise and deploy capital, to build new business, to create new management teams and companies, to assist with sourcing and screening new investment opportunities, and to provide on-call research and business support services. Read about a few of our existing mandates opposite. For more information, please get in touch.


• AIP has been mandated to raise $250m for an established lifesciences venture fund to invest in a portfolio of North American and European early stage companies.
• AIP has been mandated to raise $10m series A round for a new AI/ML-focused healthcare and pharma company using AI for drug discovery.
• AIP has been mandated to raise $20m for a clinical-stage biopharma company focused on discovering and developing innovative small-molecule drugs.

• AIP is currently in the process of building a new drugs company with an exclusive licence to commercialise in the US and UK. The focus of the company build out includes establishing a UK entity, building the UK management team (operations and sales), engaging discussions with the NHS and other groups, managing all legal and commercial activities, and raising additional capital for business expansion.

• AIP was engaged by a recently funded healthcare start-up to help build their new business development pipeline. The engagement included our research team mapping prospective new business leads who included corporates, healthcare trusts, and private hospitals. Following agreement of the target list, AIP’s team of new business consultants reached out directly to the leads via telephone, email and business social media. This was followed by numerous video telephone calls which led to qualified introductions to our client.

• AIP has been retained by a multi-family office to source up to $250m of healthcare and pharma investments with view to customising an investment portfolio. A decision will be taken by the family office on whether to invest in and manage their own portfolio or to invest via a healthcare-focused venture capital fund.
• AIP has been mandated by a major venture capital fund to source the latest seed and series A opportunities across digital health, AI/ML-focused healthcare and medical devices. The minimum deal size is $5m.

• AIP created a private introductory video for one of our digital health clients for an AIP investment webinar. The video was professionally produced by our video consultant and narrated by a BBC narrator.
• AIP and our legal counsel created a customised term sheet for a series A client who wished to use the Channel Islands for the location of the company. This also meant introducing a Channel Islands based Non-Executive Director.
• AIP created a complete business plan for a new start-up to use for fundraising. The business plan focused on a description of the business, market strategies, competition analysis, design and development, operations and management, and financial information.

AIP was mandated to hire the executive business team of a series B company. Through our DRS relationships/shareholding, we hired and onboarded the following personnel:
- Non-Executive Chairman
- COO
- Finance Director
- Head of Sales
- Head of Client Engagement

AIP is currently involved in principal investment activities with a new AI/ML company that focuses on R&D across a number of business areas, most notably in healthcare and pharmacology. The company is currently developing the latest algorithms, processes, models and techniques for specialist lifescience-focused AI/ML application areas.

AIP has been mandated to provide multiple research projects for several clients in the past quarter. A few of these include:
- Create an investor directory of all lifesciences-focused family offices worldwide
- Create an investor directory of UHNWi in North America with a net worth >$200m
- Create an investor directory of all pharma-focused VC and CVC investors worldwide
- Create a list of all healthcare and pharma companies founded in the past 3 years and amounts raised ($USD
- Build a C-level Linked-In network directory for a healthcare founder/CEO
- Build a competitor map for a new digital healthcare start-up

AIP has been mandated to provide objective views on a number lifesciences companies and funds. These included:
- Blood glucose monitoring company
- In vitro diagnostic solutions company
- Pharmacy information technology company
- Biopharmaceutical company for serious diseases and medical conditions
- Health and wellness information company
- AI-focused primary healthcare company

  • DR. WAL VAN LIEROP

    FOUNDER AND CEO, CHRYSALIX VENTURE CAPITAL
    (FINANCIAL INVESTOR OF THE YEAR, 2017)

    "An exceptional international network of industry, financial and strategic investors and partners from across the intelligent systems, technology, energy and commodities sectors. AIP and their Partner Antony Sommerfeld come highly recommended..."

  • RICHARD REDMAYNE

    FORMER CHAIRMAN, CANTOR FITZGERALD

    "[AIP] maintains an extensive network of international investment relationships with the world’s leading public and private investment groups that extends deep into the family office, endowment/foundation and ultra-private office universe, a universe which investment banks and brokerages have traditionally found difficult to access…"

  • TESSA DOLLAR

    BOARD ADVISOR. RUSANT

    "I recommend the AIP research and capital introduction service to you which, over a short period, led to qualified introductions to asset managers, private equity managers, industrial conglomerates, family offices and boutique investment management firms…"

  • Ifty Nasir

    Former CEO E&P, Essar Energy, Founder of Vestd

    "A world-class team with a demonstrable track record in origination, appraisal and principal investment"

  • PETER GIBSON

    CEO, DYNASTY FAMILY OFFICE

    "I recommend AIP to you as a leading capital introduction, services and advisory business serving the commodities, technology and healthcare/pharmacology sectors. Their team have been instrumental in accessing leading investors, executives and decision makers active in our sector which has relied heavily upon their knowledge of the commodities markets and meticulous research product"

  • ADAM SOMMERFELD

    MANAGING PARTNER, CERTUS CAPITAL PARTNERS

    "We regularly use the AIP team for ad-hoc research projects, deal origination and deal screening, as well as for incubating and funding new start-ups that we create. In fact, one of AIP’s Director’s is a Board Advisor to our business at Certus"

Video


AIP

YOUR PARTNER IN GLOBAL LIFESCIENCES

Get in touch


Contact info